Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,071 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity.
Mandour AA, Nassar IF, Abdel Aal MT, Shahin MAE, El-Sayed WA, Hegazy M, Yehia AM, Ismail A, Hagras M, Elkaeed EB, Refaat HM, Ismail NSM. Mandour AA, et al. Among authors: ismail nsm, ismail a. J Enzyme Inhib Med Chem. 2022 Dec;37(1):1957-1973. doi: 10.1080/14756366.2022.2086866. J Enzyme Inhib Med Chem. 2022. PMID: 35815597 Free PMC article.
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies.
Elkady H, Elwan A, El-Mahdy HA, Doghish AS, Ismail A, Taghour MS, Elkaeed EB, Eissa IH, Dahab MA, Mahdy HA, Khalifa MM. Elkady H, et al. Among authors: ismail a. J Enzyme Inhib Med Chem. 2022 Dec;37(1):397-410. doi: 10.1080/14756366.2021.2015343. J Enzyme Inhib Med Chem. 2022. PMID: 34961427 Free PMC article.
The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.
Hegazy M, Elkady MA, Yehia AM, Elsakka EGE, Abulsoud AI, Abdelmaksoud NM, Elshafei A, Abdelghany TM, Elkhawaga SY, Ismail A, Mokhtar MM, El-Mahdy HA, Doghish AS. Hegazy M, et al. Among authors: ismail a. Pathol Res Pract. 2023 Jun;246:154510. doi: 10.1016/j.prp.2023.154510. Epub 2023 May 8. Pathol Res Pract. 2023. PMID: 37167812 Review.
In vitro and in silico evaluation of new thieno[2,3-d]pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2.
El-Metwally SA, Abuelkhir AA, Elkady H, Taghour MS, Ibrahim IM, Husein DZ, Alsfouk AA, Sultan A, Ismail A, Elkhawaga SY, Elkaeed EB, Metwaly AM, Eissa IH. El-Metwally SA, et al. Among authors: ismail a. Comput Biol Chem. 2023 Oct;106:107928. doi: 10.1016/j.compbiolchem.2023.107928. Epub 2023 Jul 18. Comput Biol Chem. 2023. PMID: 37480629
miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma.
Elkady MA, Yehia AM, Elsakka EGE, Abulsoud AI, Abdelmaksoud NM, Elshafei A, Elkhawaga SY, Ismail A, Mokhtar MM, El-Mahdy HA, Hegazy M, Elballal MS, Mohammed OA, El-Husseiny HM, Midan HM, El-Dakroury WA, Zewail MB, Abdel Mageed SS, Doghish AS. Elkady MA, et al. Among authors: ismail a. Pathol Res Pract. 2023 Aug;248:154704. doi: 10.1016/j.prp.2023.154704. Epub 2023 Jul 22. Pathol Res Pract. 2023. PMID: 37499518 Review.
3,071 results